Overview:

The VCA IgG test specifically looks for the presence of immunoglobulin G (IgG) antibodies against the viral capsid antigen (VCA) of EBV. This test helps determine whether a person has been previously infected with EBV, which is known for causing infectious mononucleosis (mono), and it can provide insight into the timing of the infection.

Risk Assessment:

• High Risk: Close contact with someone who has an active EBV infection (e.g., kissing), especially in adolescents and young adults. It is more common in individuals aged 15–24.
• Other Risk Factors: Immunocompromised individuals (such as those with HIV or organ transplant recipients) may be at higher risk of EBV-related complications.
• Past Infection: Most people become infected with EBV in childhood or adolescence. The virus can remain dormant in the body after the initial infection.

Normal Range:

• VCA IgG: The normal range can vary depending on the laboratory performing the test, but typically, a result is reported as either positive or negative. If the test detects significant levels of IgG antibodies, it indicates past exposure.
• Unit of Measurement: The results are often reported in terms of an index value, and levels above a certain threshold (e.g., 1.0) might indicate a past infection.

Interpretation:

• Positive for VCA IgG: This indicates past infection with EBV. VCA IgG antibodies generally appear in the bloodstream shortly after the initial infection and remain detectable for life. A positive result suggests the person had an infection at some point, possibly during their youth.
• Negative for VCA IgG: A negative result typically means the person has not been previously infected with EBV. This is more likely in people who have never been exposed to the virus.

Sample Type:

• Blood (Serum): The test is usually performed using a blood sample, where serum is separated to measure the specific antibodies.